New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
08:39 EDTSNY, ASTMAastrom appoints Chief Scientific Officer, Chief Medical Officer
Aastrom Biosciences announced the appointments of Ross Tubo, PhD, as Chief Scientific Officer and David Recker, MD, FACR, FACP, as Chief Medical Officer of Aastrom. Dr. Tubo was formerly vice president of stem cell and chemokine biology at Genzyme, a Sanofi company (SNY). Dr. Recker most recently served as a senior vice president of clinical sciences at Takeda Global Research and Development.
News For ASTM;SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 30, 2015
08:28 EDTSNYSanofi has a conference call hosted by JPMorgan
Subscribe for More Information
08:16 EDTSNYPieris Pharmaceuticals achieves payment milestone in Sanofi collaboration
Subscribe for More Information
November 29, 2015
19:37 EDTSNYSanofi working with Lazard to explore sale of animal health unit, Reuters says
Lazard (LAZ) is working with Sanofi (SNY) to prepare a sale or listing of the company's Merial animal health division, which could value the unit at up to $12.7B, reports Reuters, citing sources. The investment bank is expected to land the lead advisory role for the potential deal, sources told Reuters, which added that the sale would play a "pivotal role" in getting Sanofi "back on track." Reference Link
November 24, 2015
05:23 EDTSNYSanofi, Regeneron announce Praluent ODYSSEY OUTCOMES trial enrollment complete
Subscribe for More Information
November 20, 2015
06:09 EDTSNYSanofi, AstraZeneca to exchange more than 210,000 compounds
Subscribe for More Information
November 18, 2015
08:11 EDTSNYIMS Health forecasts global drug spending to increase 30% by 2020 to $1.4T
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use